Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check5 days agoChange DetectedSchizophrenia is no longer listed as the study's condition, and the Related Topics header along with the MedlinePlus Genetics link have been removed, reducing contextual labels and external references on the page.SummaryDifference0.1%

- Check12 days agoChange DetectedSchizophrenia and MedlinePlus Genetics were added to the related topics area, and the site revision now shows Revision: v3.5.4. The previous revision label v3.5.3 was removed.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page adds an expanded related topics section, listing Schizophrenia and MedlinePlus Genetics under related topics. This connects the study to broader schizophrenia- and genetics-related resources for readers.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page lost the condition tag 'Schizophrenia' and the related topics entry for 'MedlinePlus Genetics', and the related topics section appears removed, reducing cross-links but not altering the main trial details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.